Secondary care management of malignant hypertensionStatus:Awaiting developmentExpected publication date: TBC
Treprostinil diethanolamine for treating pulmonary arterial hypertension TS ID 11772Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
10395 - Aprocitentan for treating resistant hypertension TS ID 10395Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Inhaled treprostinil for treating pulmonary hypertension caused by interstitial lung disease TS ID 11997Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC